NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,171 filers reported holding NOVARTIS A G in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,020,556 | -52.1% | 29,654 | -52.5% | 0.03% | -52.4% |
| Q2 2023 | $6,305,059 | +111.8% | 62,482 | +93.1% | 0.06% | +96.9% |
| Q1 2023 | $2,976,407 | -31.6% | 32,352 | -32.5% | 0.03% | -17.9% |
| Q4 2022 | $4,351,022 | -99.9% | 47,961 | -66.9% | 0.04% | -33.9% |
| Q3 2022 | $5,519,514,000 | +171526.7% | 145,092 | +281.3% | 0.06% | +78.8% |
| Q2 2022 | $3,216,000 | +8.4% | 38,047 | +12.6% | 0.03% | +6.5% |
| Q1 2022 | $2,966,000 | -46.5% | 33,800 | -46.7% | 0.03% | -44.6% |
| Q4 2021 | $5,548,000 | -40.1% | 63,430 | -44.0% | 0.06% | -39.8% |
| Q3 2021 | $9,255,000 | +53.6% | 113,168 | +71.4% | 0.09% | +36.8% |
| Q2 2021 | $6,026,000 | +3.1% | 66,041 | -3.4% | 0.07% | -8.1% |
| Q1 2021 | $5,845,000 | -48.0% | 68,378 | -42.6% | 0.07% | -43.1% |
| Q4 2020 | $11,233,000 | -99.8% | 119,043 | +101.5% | 0.13% | +35.4% |
| Q3 2020 | $5,137,000,000 | – | 59,078 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |